Search NLS News

This Nobel Prize-special issue includes for example exclusive interviews with Medicine Laureate Katalin Karikó and Chemistry Laureate Moungi Bawendi. The Nobel Prize-special section also includes articles about the other Nobel Prize Laureates in Medicine and Chemistry and in-depth articles about nucleoside base modifications and mRNA, quantum dots and attosecond physics, and their applications within life […]

Residents in the Gothenburg area have very little knowledge of the life science sector, shows a new survey from Novus, an analysis and research company. For this reason, six major life science players are marking the start of a joint communicative effort, with the goal of putting the West Swedish life science sector on the […]

BICO has divested Ginolis through a management buy-out to Ginolis’ current CEO Kauko Väinämö. The purchase price amounted to USD 1. The transaction is estimated to result in a divestment loss of SEK -25 million, which is a non-cash item. Final divestment result will be reported and disclosed in the Q4 report, states the company. […]

ProtaGene is a world-leading analytic CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we provide the most advanced, integrated, and Quality system driven analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms. Our deep history of analytical leadership in protein-based therapeutics […]

The management team is welcoming two new members, Christina Erixon, Head of Pharmaceutical Development & Operations, who is replacing Agneta Larhed, and Robert Ehrl, Head of Supply, who is taking over from Jesper Lind. Both roles have been expanded from part-time consultants to full-time positions. Agneta Larhed is leaving the executive team but will remain […]

The Finnish Genomics initiative FinnGen has entered its next phase, backed by EUR 52 million of new funding. Since its initiation in 2017, FinnGen has developed into one of the world’s leading biobank-based genomic research projects. It has completed the construction of a research resource that integrates genomic information from half a million Finnish biobank […]

The Board of Directors of Modus Therapeutics Holding has resolved to carry out a new issue of up to 20,125,060 shares with pre-emptive rights for the company’s shareholders, as well as a directed issue of 10,156,569 shares through the offsetting of loans from Karolinska Development AB amounting to approximately SEK 20.3 million. The Rights Issue […]

The Board of Directors of Medivir has resolved to carry out a new issue of shares with preferential rights for existing shareholders of approximately SEK 148 million. An extraordinary general meeting is proposed to approve the Board of Directors’ resolution on the Rights Issue. The EGM is set to be held on 1 December 2023. […]

The results of a prospective multicenter study conducted in collaboration with Umeå University and eight Swedish hospitals have been published in the International Journal of Cancer. The study shows that HiloProbe’s ColoNode kit can identify more patients at risk of tumor recurrence following surgery compared to today’s standard method, states the company. “ColoNode can both […]

The company has entered into a collaboration agreement with DiaUnion, a center of excellence in type 1 diabetes, to identify participants for the DiaPrecise trial. DiaPrecise is an open-label trial evaluating the safety, feasibility and immune response of intralymphatic injections of Diamyd in children at risk of developing type 1 diabetes who also carry the […]